Delivery Order SPE2DB24D2205-SPE2DB25FEGEK
- Not listed
- On September 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $3,640.14 to AmerisourceBergen Drug Corp for the supply of Viscoat Syringe 0.5ML medical devices. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 19, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,066.90 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes in 0.5ML configuration. This competitive, non-set-aside contract operates under a firm fixed price structure with an ultimate completion date of July 30, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,976.17 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) on May 9, 2025, with completion scheduled for May 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Viscoat syringes (0.5ml) valued at $27,117.66. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion comprehensive pharmaceutical support vehicle running through December 2026. Performance will take place at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 0.75 mL Viscoat syringes valued at $6,839.52 on September 24, 2025, with completion expected by September 25, 2025. This non-competitive, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $4,853.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $8,825.82 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Viscoat Syringes in 0.5ml quantities. The delivery order, which closes on July 24, 2025, represents a competitively awarded contract with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,172.83 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes (0.5mL) under a firm fixed-price contract. The order, awarded on September 22, 2025, with an ultimate completion date of September 23, 2025, will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $2,426.76 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Viscoat syringes (0.5 mL). This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract requires completion by September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,928.50 to AmerisourceBergen Drug Corp for Viscoat syringes (0.5mL) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded procurement for medical supply fulfillment. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGEKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,058.51 to AmerisourceBergen Drug Corp for the supply of Viscoat syringes in 0.5 mL quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 14, 2025, issued on August 13, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies an extensive portfolio of medications and medical devices to military and veteran healthcare systems through the Defense Logistics Agency. The company's federal contract awards demonstrate consistent capability to fulfill competitively awarded procurement requirements across diverse therapeutic domains, ranging from specialty medications and vaccines to medical supplies and devices. This delivery order reflects the company's ongoing role in supporting the Defense Health Agency and broader U.S. military medical supply chain through the DLA's pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 8/13/25 |